Global Tuberculosis (TB) Treatment Market Growth (Status and Outlook) 2022-2028
- LP 4917552
- 87 Pages
- March 2022
- Medical Devices
The United States Tuberculosis (TB) Treatment market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Tuberculosis (TB) Treatment market, reaching US$ million by the year 2028. As for the Europe Tuberculosis (TB) Treatment landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Tuberculosis (TB) Treatment players cover Johnson & Johnson, Otsuka Pharmaceutical Co., Ltd, Macleods Pharmaceutical Ltd, and Dong-A ST Co., Ltd, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Tuberculosis (TB) Treatment market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Isoniazid
Rifampin (Rifadin, Rimactane)
Ethambutol (Myambutol)
Pyrazinamide
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Active TB
Latent TB
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Johnson & Johnson
Otsuka Pharmaceutical Co., Ltd
Macleods Pharmaceutical Ltd
Dong-A ST Co., Ltd
Lupin Ltd
Janssen Products, LP
Mylan
Sanofi
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Tuberculosis (TB) Treatment Market Size 2017-2028
2.1.2 Tuberculosis (TB) Treatment Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Tuberculosis (TB) Treatment Segment by Type
2.2.1 Isoniazid
2.2.2 Rifampin (Rifadin, Rimactane)
2.2.3 Ethambutol (Myambutol)
2.2.4 Pyrazinamide
2.3 Tuberculosis (TB) Treatment Market Size by Type
2.3.1 Tuberculosis (TB) Treatment Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Tuberculosis (TB) Treatment Market Size Market Share by Type (2017-2022)
2.4 Tuberculosis (TB) Treatment Segment by Application
2.4.1 Active TB
2.4.2 Latent TB
2.5 Tuberculosis (TB) Treatment Market Size by Application
2.5.1 Tuberculosis (TB) Treatment Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Tuberculosis (TB) Treatment Market Size Market Share by Application (2017-2022)
3 Tuberculosis (TB) Treatment Market Size by Player
3.1 Tuberculosis (TB) Treatment Market Size Market Share by Players
3.1.1 Global Tuberculosis (TB) Treatment Revenue by Players (2020-2022)
3.1.2 Global Tuberculosis (TB) Treatment Revenue Market Share by Players (2020-2022)
3.2 Global Tuberculosis (TB) Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Tuberculosis (TB) Treatment by Regions
4.1 Tuberculosis (TB) Treatment Market Size by Regions (2017-2022)
4.2 Americas Tuberculosis (TB) Treatment Market Size Growth (2017-2022)
4.3 APAC Tuberculosis (TB) Treatment Market Size Growth (2017-2022)
4.4 Europe Tuberculosis (TB) Treatment Market Size Growth (2017-2022)
4.5 Middle East & Africa Tuberculosis (TB) Treatment Market Size Growth (2017-2022)
5 Americas
5.1 Americas Tuberculosis (TB) Treatment Market Size by Country (2017-2022)
5.2 Americas Tuberculosis (TB) Treatment Market Size by Type (2017-2022)
5.3 Americas Tuberculosis (TB) Treatment Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Tuberculosis (TB) Treatment Market Size by Region (2017-2022)
6.2 APAC Tuberculosis (TB) Treatment Market Size by Type (2017-2022)
6.3 APAC Tuberculosis (TB) Treatment Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Tuberculosis (TB) Treatment by Country (2017-2022)
7.2 Europe Tuberculosis (TB) Treatment Market Size by Type (2017-2022)
7.3 Europe Tuberculosis (TB) Treatment Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Tuberculosis (TB) Treatment by Region (2017-2022)
8.2 Middle East & Africa Tuberculosis (TB) Treatment Market Size by Type (2017-2022)
8.3 Middle East & Africa Tuberculosis (TB) Treatment Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Tuberculosis (TB) Treatment Market Forecast
10.1 Global Tuberculosis (TB) Treatment Forecast by Regions (2023-2028)
10.1.1 Global Tuberculosis (TB) Treatment Forecast by Regions (2023-2028)
10.1.2 Americas Tuberculosis (TB) Treatment Forecast
10.1.3 APAC Tuberculosis (TB) Treatment Forecast
10.1.4 Europe Tuberculosis (TB) Treatment Forecast
10.1.5 Middle East & Africa Tuberculosis (TB) Treatment Forecast
10.2 Americas Tuberculosis (TB) Treatment Forecast by Country (2023-2028)
10.2.1 United States Tuberculosis (TB) Treatment Market Forecast
10.2.2 Canada Tuberculosis (TB) Treatment Market Forecast
10.2.3 Mexico Tuberculosis (TB) Treatment Market Forecast
10.2.4 Brazil Tuberculosis (TB) Treatment Market Forecast
10.3 APAC Tuberculosis (TB) Treatment Forecast by Region (2023-2028)
10.3.1 China Tuberculosis (TB) Treatment Market Forecast
10.3.2 Japan Tuberculosis (TB) Treatment Market Forecast
10.3.3 Korea Tuberculosis (TB) Treatment Market Forecast
10.3.4 Southeast Asia Tuberculosis (TB) Treatment Market Forecast
10.3.5 India Tuberculosis (TB) Treatment Market Forecast
10.3.6 Australia Tuberculosis (TB) Treatment Market Forecast
10.4 Europe Tuberculosis (TB) Treatment Forecast by Country (2023-2028)
10.4.1 Germany Tuberculosis (TB) Treatment Market Forecast
10.4.2 France Tuberculosis (TB) Treatment Market Forecast
10.4.3 UK Tuberculosis (TB) Treatment Market Forecast
10.4.4 Italy Tuberculosis (TB) Treatment Market Forecast
10.4.5 Russia Tuberculosis (TB) Treatment Market Forecast
10.5 Middle East & Africa Tuberculosis (TB) Treatment Forecast by Region (2023-2028)
10.5.1 Egypt Tuberculosis (TB) Treatment Market Forecast
10.5.2 South Africa Tuberculosis (TB) Treatment Market Forecast
10.5.3 Israel Tuberculosis (TB) Treatment Market Forecast
10.5.4 Turkey Tuberculosis (TB) Treatment Market Forecast
10.5.5 GCC Countries Tuberculosis (TB) Treatment Market Forecast
10.6 Global Tuberculosis (TB) Treatment Forecast by Type (2023-2028)
10.7 Global Tuberculosis (TB) Treatment Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Information
11.1.2 Johnson & Johnson Tuberculosis (TB) Treatment Product Offered
11.1.3 Johnson & Johnson Tuberculosis (TB) Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Johnson & Johnson Main Business Overview
11.1.5 Johnson & Johnson Latest Developments
11.2 Otsuka Pharmaceutical Co., Ltd
11.2.1 Otsuka Pharmaceutical Co., Ltd Company Information
11.2.2 Otsuka Pharmaceutical Co., Ltd Tuberculosis (TB) Treatment Product Offered
11.2.3 Otsuka Pharmaceutical Co., Ltd Tuberculosis (TB) Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Otsuka Pharmaceutical Co., Ltd Main Business Overview
11.2.5 Otsuka Pharmaceutical Co., Ltd Latest Developments
11.3 Macleods Pharmaceutical Ltd
11.3.1 Macleods Pharmaceutical Ltd Company Information
11.3.2 Macleods Pharmaceutical Ltd Tuberculosis (TB) Treatment Product Offered
11.3.3 Macleods Pharmaceutical Ltd Tuberculosis (TB) Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Macleods Pharmaceutical Ltd Main Business Overview
11.3.5 Macleods Pharmaceutical Ltd Latest Developments
11.4 Dong-A ST Co., Ltd
11.4.1 Dong-A ST Co., Ltd Company Information
11.4.2 Dong-A ST Co., Ltd Tuberculosis (TB) Treatment Product Offered
11.4.3 Dong-A ST Co., Ltd Tuberculosis (TB) Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Dong-A ST Co., Ltd Main Business Overview
11.4.5 Dong-A ST Co., Ltd Latest Developments
11.5 Lupin Ltd
11.5.1 Lupin Ltd Company Information
11.5.2 Lupin Ltd Tuberculosis (TB) Treatment Product Offered
11.5.3 Lupin Ltd Tuberculosis (TB) Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Lupin Ltd Main Business Overview
11.5.5 Lupin Ltd Latest Developments
11.6 Janssen Products, LP
11.6.1 Janssen Products, LP Company Information
11.6.2 Janssen Products, LP Tuberculosis (TB) Treatment Product Offered
11.6.3 Janssen Products, LP Tuberculosis (TB) Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Janssen Products, LP Main Business Overview
11.6.5 Janssen Products, LP Latest Developments
11.7 Mylan
11.7.1 Mylan Company Information
11.7.2 Mylan Tuberculosis (TB) Treatment Product Offered
11.7.3 Mylan Tuberculosis (TB) Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Mylan Main Business Overview
11.7.5 Mylan Latest Developments
11.8 Sanofi
11.8.1 Sanofi Company Information
11.8.2 Sanofi Tuberculosis (TB) Treatment Product Offered
11.8.3 Sanofi Tuberculosis (TB) Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Sanofi Main Business Overview
11.8.5 Sanofi Latest Developments
12 Research Findings and Conclusion
Table 1. Tuberculosis (TB) Treatment Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Isoniazid
Table 3. Major Players of Rifampin (Rifadin, Rimactane)
Table 4. Major Players of Ethambutol (Myambutol)
Table 5. Major Players of Pyrazinamide
Table 6. Tuberculosis (TB) Treatment Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 7. Global Tuberculosis (TB) Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 8. Global Tuberculosis (TB) Treatment Market Size Market Share by Type (2017-2022)
Table 9. Tuberculosis (TB) Treatment Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 10. Global Tuberculosis (TB) Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 11. Global Tuberculosis (TB) Treatment Market Size Market Share by Application (2017-2022)
Table 12. Global Tuberculosis (TB) Treatment Revenue by Players (2020-2022) & ($ Millions)
Table 13. Global Tuberculosis (TB) Treatment Revenue Market Share by Player (2020-2022)
Table 14. Tuberculosis (TB) Treatment Key Players Head office and Products Offered
Table 15. Tuberculosis (TB) Treatment Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Tuberculosis (TB) Treatment Market Size by Regions 2017-2022 & ($ Millions)
Table 19. Global Tuberculosis (TB) Treatment Market Size Market Share by Regions (2017-2022)
Table 20. Americas Tuberculosis (TB) Treatment Market Size by Country (2017-2022) & ($ Millions)
Table 21. Americas Tuberculosis (TB) Treatment Market Size Market Share by Country (2017-2022)
Table 22. Americas Tuberculosis (TB) Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 23. Americas Tuberculosis (TB) Treatment Market Size Market Share by Type (2017-2022)
Table 24. Americas Tuberculosis (TB) Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 25. Americas Tuberculosis (TB) Treatment Market Size Market Share by Application (2017-2022)
Table 26. APAC Tuberculosis (TB) Treatment Market Size by Region (2017-2022) & ($ Millions)
Table 27. APAC Tuberculosis (TB) Treatment Market Size Market Share by Region (2017-2022)
Table 28. APAC Tuberculosis (TB) Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 29. APAC Tuberculosis (TB) Treatment Market Size Market Share by Type (2017-2022)
Table 30. APAC Tuberculosis (TB) Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 31. APAC Tuberculosis (TB) Treatment Market Size Market Share by Application (2017-2022)
Table 32. Europe Tuberculosis (TB) Treatment Market Size by Country (2017-2022) & ($ Millions)
Table 33. Europe Tuberculosis (TB) Treatment Market Size Market Share by Country (2017-2022)
Table 34. Europe Tuberculosis (TB) Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 35. Europe Tuberculosis (TB) Treatment Market Size Market Share by Type (2017-2022)
Table 36. Europe Tuberculosis (TB) Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 37. Europe Tuberculosis (TB) Treatment Market Size Market Share by Application (2017-2022)
Table 38. Middle East & Africa Tuberculosis (TB) Treatment Market Size by Region (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Tuberculosis (TB) Treatment Market Size Market Share by Region (2017-2022)
Table 40. Middle East & Africa Tuberculosis (TB) Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Tuberculosis (TB) Treatment Market Size Market Share by Type (2017-2022)
Table 42. Middle East & Africa Tuberculosis (TB) Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 43. Middle East & Africa Tuberculosis (TB) Treatment Market Size Market Share by Application (2017-2022)
Table 44. Key Market Drivers & Growth Opportunities of Tuberculosis (TB) Treatment
Table 45. Key Market Challenges & Risks of Tuberculosis (TB) Treatment
Table 46. Key Industry Trends of Tuberculosis (TB) Treatment
Table 47. Global Tuberculosis (TB) Treatment Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 48. Global Tuberculosis (TB) Treatment Market Size Market Share Forecast by Regions (2023-2028)
Table 49. Global Tuberculosis (TB) Treatment Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 50. Global Tuberculosis (TB) Treatment Market Size Market Share Forecast by Type (2023-2028)
Table 51. Global Tuberculosis (TB) Treatment Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 52. Global Tuberculosis (TB) Treatment Market Size Market Share Forecast by Application (2023-2028)
Table 53. Johnson & Johnson Details, Company Type, Tuberculosis (TB) Treatment Area Served and Its Competitors
Table 54. Johnson & Johnson Tuberculosis (TB) Treatment Product Offered
Table 55. Johnson & Johnson Tuberculosis (TB) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 56. Johnson & Johnson Main Business
Table 57. Johnson & Johnson Latest Developments
Table 58. Otsuka Pharmaceutical Co., Ltd Details, Company Type, Tuberculosis (TB) Treatment Area Served and Its Competitors
Table 59. Otsuka Pharmaceutical Co., Ltd Tuberculosis (TB) Treatment Product Offered
Table 60. Otsuka Pharmaceutical Co., Ltd Main Business
Table 61. Otsuka Pharmaceutical Co., Ltd Tuberculosis (TB) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 62. Otsuka Pharmaceutical Co., Ltd Latest Developments
Table 63. Macleods Pharmaceutical Ltd Details, Company Type, Tuberculosis (TB) Treatment Area Served and Its Competitors
Table 64. Macleods Pharmaceutical Ltd Tuberculosis (TB) Treatment Product Offered
Table 65. Macleods Pharmaceutical Ltd Main Business
Table 66. Macleods Pharmaceutical Ltd Tuberculosis (TB) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 67. Macleods Pharmaceutical Ltd Latest Developments
Table 68. Dong-A ST Co., Ltd Details, Company Type, Tuberculosis (TB) Treatment Area Served and Its Competitors
Table 69. Dong-A ST Co., Ltd Tuberculosis (TB) Treatment Product Offered
Table 70. Dong-A ST Co., Ltd Main Business
Table 71. Dong-A ST Co., Ltd Tuberculosis (TB) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 72. Dong-A ST Co., Ltd Latest Developments
Table 73. Lupin Ltd Details, Company Type, Tuberculosis (TB) Treatment Area Served and Its Competitors
Table 74. Lupin Ltd Tuberculosis (TB) Treatment Product Offered
Table 75. Lupin Ltd Main Business
Table 76. Lupin Ltd Tuberculosis (TB) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 77. Lupin Ltd Latest Developments
Table 78. Janssen Products, LP Details, Company Type, Tuberculosis (TB) Treatment Area Served and Its Competitors
Table 79. Janssen Products, LP Tuberculosis (TB) Treatment Product Offered
Table 80. Janssen Products, LP Main Business
Table 81. Janssen Products, LP Tuberculosis (TB) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 82. Janssen Products, LP Latest Developments
Table 83. Mylan Details, Company Type, Tuberculosis (TB) Treatment Area Served and Its Competitors
Table 84. Mylan Tuberculosis (TB) Treatment Product Offered
Table 85. Mylan Main Business
Table 86. Mylan Tuberculosis (TB) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 87. Mylan Latest Developments
Table 88. Sanofi Details, Company Type, Tuberculosis (TB) Treatment Area Served and Its Competitors
Table 89. Sanofi Tuberculosis (TB) Treatment Product Offered
Table 90. Sanofi Main Business
Table 91. Sanofi Tuberculosis (TB) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 92. Sanofi Latest Developments
List of Figures
Figure 1. Tuberculosis (TB) Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Tuberculosis (TB) Treatment Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Tuberculosis (TB) Treatment Market Size Market Share by Type in 2021
Figure 7. Tuberculosis (TB) Treatment in Active TB
Figure 8. Global Tuberculosis (TB) Treatment Market: Active TB (2017-2022) & ($ Millions)
Figure 9. Tuberculosis (TB) Treatment in Latent TB
Figure 10. Global Tuberculosis (TB) Treatment Market: Latent TB (2017-2022) & ($ Millions)
Figure 11. Global Tuberculosis (TB) Treatment Market Size Market Share by Application in 2021
Figure 12. Global Tuberculosis (TB) Treatment Revenue Market Share by Player in 2021
Figure 13. Global Tuberculosis (TB) Treatment Market Size Market Share by Regions (2017-2022)
Figure 14. Americas Tuberculosis (TB) Treatment Market Size 2017-2022 ($ Millions)
Figure 15. APAC Tuberculosis (TB) Treatment Market Size 2017-2022 ($ Millions)
Figure 16. Europe Tuberculosis (TB) Treatment Market Size 2017-2022 ($ Millions)
Figure 17. Middle East & Africa Tuberculosis (TB) Treatment Market Size 2017-2022 ($ Millions)
Figure 18. Americas Tuberculosis (TB) Treatment Value Market Share by Country in 2021
Figure 19. Americas Tuberculosis (TB) Treatment Consumption Market Share by Type in 2021
Figure 20. Americas Tuberculosis (TB) Treatment Market Size Market Share by Application in 2021
Figure 21. United States Tuberculosis (TB) Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 22. Canada Tuberculosis (TB) Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 23. Mexico Tuberculosis (TB) Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 24. Brazil Tuberculosis (TB) Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 25. APAC Tuberculosis (TB) Treatment Market Size Market Share by Region in 2021
Figure 26. APAC Tuberculosis (TB) Treatment Market Size Market Share by Application in 2021
Figure 27. China Tuberculosis (TB) Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 28. Japan Tuberculosis (TB) Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 29. Korea Tuberculosis (TB) Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 30. Southeast Asia Tuberculosis (TB) Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 31. India Tuberculosis (TB) Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 32. Australia Tuberculosis (TB) Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 33. Europe Tuberculosis (TB) Treatment Market Size Market Share by Country in 2021
Figure 34. Europe Tuberculosis (TB) Treatment Market Size Market Share by Type in 2021
Figure 35. Europe Tuberculosis (TB) Treatment Market Size Market Share by Application in 2021
Figure 36. Germany Tuberculosis (TB) Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 37. France Tuberculosis (TB) Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 38. UK Tuberculosis (TB) Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 39. Italy Tuberculosis (TB) Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 40. Russia Tuberculosis (TB) Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 41. Middle East & Africa Tuberculosis (TB) Treatment Market Size Market Share by Region in 2021
Figure 42. Middle East & Africa Tuberculosis (TB) Treatment Market Size Market Share by Type in 2021
Figure 43. Middle East & Africa Tuberculosis (TB) Treatment Market Size Market Share by Application in 2021
Figure 44. Egypt Tuberculosis (TB) Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 45. South Africa Tuberculosis (TB) Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 46. Israel Tuberculosis (TB) Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 47. Turkey Tuberculosis (TB) Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 48. GCC Country Tuberculosis (TB) Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 49. Americas Tuberculosis (TB) Treatment Market Size 2023-2028 ($ Millions)
Figure 50. APAC Tuberculosis (TB) Treatment Market Size 2023-2028 ($ Millions)
Figure 51. Europe Tuberculosis (TB) Treatment Market Size 2023-2028 ($ Millions)
Figure 52. Middle East & Africa Tuberculosis (TB) Treatment Market Size 2023-2028 ($ Millions)
Figure 53. United States Tuberculosis (TB) Treatment Market Size 2023-2028 ($ Millions)
Figure 54. Canada Tuberculosis (TB) Treatment Market Size 2023-2028 ($ Millions)
Figure 55. Mexico Tuberculosis (TB) Treatment Market Size 2023-2028 ($ Millions)
Figure 56. Brazil Tuberculosis (TB) Treatment Market Size 2023-2028 ($ Millions)
Figure 57. China Tuberculosis (TB) Treatment Market Size 2023-2028 ($ Millions)
Figure 58. Japan Tuberculosis (TB) Treatment Market Size 2023-2028 ($ Millions)
Figure 59. Korea Tuberculosis (TB) Treatment Market Size 2023-2028 ($ Millions)
Figure 60. Southeast Asia Tuberculosis (TB) Treatment Market Size 2023-2028 ($ Millions)
Figure 61. India Tuberculosis (TB) Treatment Market Size 2023-2028 ($ Millions)
Figure 62. Australia Tuberculosis (TB) Treatment Market Size 2023-2028 ($ Millions)
Figure 63. Germany Tuberculosis (TB) Treatment Market Size 2023-2028 ($ Millions)
Figure 64. France Tuberculosis (TB) Treatment Market Size 2023-2028 ($ Millions)
Figure 65. UK Tuberculosis (TB) Treatment Market Size 2023-2028 ($ Millions)
Figure 66. Italy Tuberculosis (TB) Treatment Market Size 2023-2028 ($ Millions)
Figure 67. Russia Tuberculosis (TB) Treatment Market Size 2023-2028 ($ Millions)
Figure 68. Spain Tuberculosis (TB) Treatment Market Size 2023-2028 ($ Millions)
Figure 69. Egypt Tuberculosis (TB) Treatment Market Size 2023-2028 ($ Millions)
Figure 70. South Africa Tuberculosis (TB) Treatment Market Size 2023-2028 ($ Millions)
Figure 71. Israel Tuberculosis (TB) Treatment Market Size 2023-2028 ($ Millions)
Figure 72. Turkey Tuberculosis (TB) Treatment Market Size 2023-2028 ($ Millions)
Figure 73. GCC Countries Tuberculosis (TB) Treatment Market Size 2023-2028 ($ Millions)
Similar Reports
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
